Medication That Inhibits PCSK9 Safely Reduces Cardiovascular Risk in Patients with Type 2 Diabetes - PR Newswire (press release)
<img alt="" height="1" width="1">
Medication That Inhibits PCSK9 Safely Reduces Cardiovascular Risk in Patients with Type 2 Diabetes
PR Newswire (press release)
... lipoprotein a (Lp), high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), triglyceride rich lipoproteins (TGRLs), apolipoprotein A-1 (Apo A-1), apolipoprotein C-III (Apo C-III), lipid subfractions by nuclear magnetic resonance (NMR ...
and more »
Medication That Inhibits PCSK9 Safely Reduces Cardiovascular Risk in Patients with Type 2 Diabetes - PR Newswire (press release)
More...
nmrlearner
Online News
0
06-11-2017 06:00 PM
[NMR paper] Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
http://www.bionmr.com//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.portlandpress.com-images-linkout-CS_pm120_VOR.jpg Related Articles Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
Clin Sci (Lond). 2015 Jun;128(12):877-82
Authors: Guardiola M, Plana N, Ibarretxe D, Cabré A, González M, Ribalta J, Masana L
...
nmrlearner
Journal club
0
05-27-2015 10:39 AM
More from JUPITER: HDL not predictive of risk at very low LDL levels - TheHeart.Org
More from JUPITER: HDL not predictive of risk at very low LDL levels - TheHeart.Org
<img alt="" height="1" width="1" />
More from JUPITER: HDL not predictive of risk at very low LDL levels
TheHeart.Org
... shown no longer predict risk on statin treatment; only measures of LDL particle concentration using NMR or apoB assays correlated with residual risk. ...
and more »
Read here